Item 8.01 Other Events.

We previously disclosed in our Current Report on Form 8-K dated November 12, 2020 (as subsequently amended by our Current Report on Form 8-K/A dated on November 13, 2019) (collectively, the "November 12 8-K") that our private placement of 9,765,933 shares of our common stock and warrants to purchase 9,765,933 shares of our common stock resulting in aggregate gross proceeds to us of approximately $18.1 million (the "Private Placement") would close simultaneously with the consummation of our Agreement and Plan of Merger and Reorganization with MyMD Pharmaceuticals, Inc. and XYZ Merger Sub, Inc. (also reported in the November 12 8-K). Notwithstanding the prior disclosure, the Private Placement is expected to close on or around November 16, 2020.

© Edgar Online, source Glimpses